# Whey Protein Supplementation in Patients With Parkinson's Disease

> **NCT05523791** · NA · COMPLETED · sponsor: **Ospedale Generale Di Zona Moriggia-Pelascini** · enrollment: 51 (actual)

## Conditions studied

- Parkinson Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Fortiral
- **DIETARY_SUPPLEMENT:** Mg++

## Key facts

- **NCT ID:** NCT05523791
- **Lead sponsor:** Ospedale Generale Di Zona Moriggia-Pelascini
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-01-01
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-06-30
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2022-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05523791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05523791, "Whey Protein Supplementation in Patients With Parkinson's Disease". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT05523791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*